ORTHOPEDIATRICS CORP
KIDSUS売上高
$236M
百万USD
営業利益
$-39M
百万USD
純利益
$-40M
百万USD
ROE
-11.4%
最新FY
EPS
$-1.69
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $21M | $-10M | $-0.54 |
| FY2021 | Q2 | $27M | $-4M | $-0.19 |
| FY2021 | Q3 | $25M | $-2M | $-0.11 |
| FY2021 | FY | $98M | $-16M | $-0.84 |
| FY2022 | Q1 | $23M | $-9M | $-0.47 |
| FY2022 | Q2 | $33M | $-0M | $-0.02 |
| FY2022 | Q3 | $35M | $19M | $0.87 |
| FY2022 | FY | $122M | $1M | $0.06 |
| FY2023 | Q1 | $32M | $-7M | $-0.30 |
| FY2023 | Q2 | $40M | $-3M | $-0.13 |
| FY2023 | Q3 | $40M | $-5M | $-0.20 |
| FY2023 | FY | $149M | $-21M | $-0.92 |
| FY2024 | Q1 | $45M | $-8M | $-0.34 |
| FY2024 | Q2 | $53M | $-6M | $-0.26 |
| FY2024 | Q3 | $55M | $-8M | $-0.34 |
| FY2024 | FY | $205M | $-38M | $-1.64 |
| FY2025 | Q1 | $52M | $-11M | $-0.46 |
| FY2025 | Q2 | $61M | $-7M | $-0.30 |
| FY2025 | Q3 | $61M | $-12M | $-0.50 |
| FY2025 | FY | $236M | $-40M | $-1.69 |
| FY2026 | Q1 | $59M | $-11M | $-0.45 |
財務データ
| 指標 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | $58M | $73M | $71M | $98M | $122M | $149M | $205M | $236M |
| 営業利益 | $-6M | $-10M | $-9M | $-27M | $-18M | $-25M | $-27M | $-35M | $-39M |
| 純利益 | $-9M | $-12M | $-14M | $-33M | $-16M | $1M | $-21M | $-38M | $-40M |
| 総資産 | $82M | $112M | $195M | $320M | $304M | $428M | $439M | $473M | $509M |
| 純資産 | - | - | - | - | - | - | - | - | - |
| 自己資本 | $47M | $82M | $142M | $235M | $225M | $379M | $377M | $355M | $347M |
| 営業CF | $-7M | $-16M | $-18M | $-19M | $-13M | $-22M | $-27M | $-27M | $-5M |
| EPS | - | - | - | - | $-0.84 | $0.06 | $-0.92 | $-1.64 | $-1.69 |
| BPS | $3.72 | $5.62 | $8.43 | $11.94 | $11.41 | $16.47 | $16.01 | $14.60 | $13.71 |
| ROE | -18.8% | -14.7% | -9.6% | -14.0% | -7.2% | 0.3% | -5.6% | -10.7% | -11.4% |